Somatropin (HGH) (24IU)
Specyfikacja techniczna
| Czystość (HPLC) | ≥98% (SDS-PAGE / HPLC) |
| Numer CAS | 12629-01-5 |
| Forma | White lyophilized powder |
| Przechowywanie | -20°C |
| Sekwencja | 191-AA single-chain polypeptide identical to endogenous human pituitary hGH |
| Masa cząsteczkowa | 22,124 g/mol |
| Forma soli | Acetate |
| Rozpuszczalność | Soluble in sterile water; typically supplied with accompanying diluent |
Somatropin (HGH) (24IU)
Cena katalogowa w EUR · HU, SK, CZ, PL
- Eurozone (EUR)240,00 EUR
- Węgry (HU)240,00 EUR≈ 96 000 Ft
- Słowacja (SK)240,00 EUR
- Czechy (CZ)240,00 EUR≈ 6 000 Kč
- Polska (PL)240,00 EUR≈ 1020,00 zł
Ta sama cena katalogowa w EUR przy dostawie na Węgry, Słowację, Czechy i Polskę. Płatność w EUR.
Orientacyjne kwoty HUF, CZK i PLN przeliczone z EUR; Słowacja stosuje EUR. Kursy przybliżone. Płatność w EUR.
Somatropina (rhGH) 24 IU — rekombinowany ludzki hormon wzrostu dla badań osi GH/IGF-1 i modeli anabolicznych. Liofilizat do przechowywania w chłodzie zgodnie z COA. Wyłącznie RUO — do badań laboratoryjnych; nie do spożycia przez ludzi.
Wyłącznie do badań laboratoryjnych.
Nie do spożycia przez ludzi, zastosowań weterynaryjnych ani diagnostycznych.
From the Peptide Explorer
A 191-amino-acid single-chain polypeptide hormone produced via recombinant DNA technology. Binds the growth hormone receptor (GHR) to trigger JAK2-STAT5 signaling, driving IGF-1 production in the liver and exerting direct anabolic, lipolytic, and metabolic effects across peripheral tissues.
Key Mechanisms
- ›GHR receptor dimerization
- ›JAK2-STAT5 signal transduction
- ›Hepatic IGF-1 induction
- ›Direct lipolysis via hormone-sensitive lipase
- ›Counterregulation of insulin
Primary Research Areas
- ›GH deficiency models
- ›Sarcopenia and aging
- ›Body composition research
- ›Wound healing and post-surgical recovery
- ›Metabolic research
Key Research Findings
- Reduced visceral adiposity and improved lipid profile in GH-deficient adults (Johannsson et al., 1997)
- Increased lean body mass and decreased fat mass in hypopituitary cohorts (Cuneo et al., 1991)
- Restored IGF-1 to youthful levels in aged subjects (Rudman et al., NEJM 1990)
Research Overview
A 191-amino-acid single-chain polypeptide hormone produced via recombinant DNA technology. Binds the growth hormone receptor (GHR) to trigger JAK2-STAT5 signaling, driving IGF-1 production in the liver and exerting direct anabolic, lipolytic, and metabolic effects across peripheral tissues.
Origin: Produced by recombinant E. coli expression; sequence identical to pituitary-derived human GH
Mechanism of Action
- GHR receptor dimerization
- JAK2-STAT5 signal transduction
- Hepatic IGF-1 induction
- Direct lipolysis via hormone-sensitive lipase
- Counterregulation of insulin
Primary Research Areas
- GH deficiency models
- Sarcopenia and aging
- Body composition research
- Wound healing and post-surgical recovery
- Metabolic research
Key Published Findings
- Reduced visceral adiposity and improved lipid profile in GH-deficient adults (Johannsson et al., 1997)
- Increased lean body mass and decreased fat mass in hypopituitary cohorts (Cuneo et al., 1991)
- Restored IGF-1 to youthful levels in aged subjects (Rudman et al., NEJM 1990)
Research Protocol
Commonly studied routes: Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
Lyophilized powder stored at 2-8°C. Reconstituted solution 2-8°C, do not freeze
Important Notice
Somatropin (HGH) (24IU) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Specyfikacja badawcza
Synthesized for strict analytical consistency. Verified via HPLC/MS.Zobacz standardy jakości →
Przechowywanie i obsługa
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in sterile water; typically supplied with accompanying diluent